A federal appeals court has ruled that the Trump administration's family planning rule can go into effect as several lawsuits over the rule play out; Missouri's only abortion clinic will defy the state by refusing to perform a required pelvic exam days before an abortion; the World Health Organization (WHO) has removed 2 guidelines on opioids following allegations of industry influence.
The 9th US Circuit Court of Appeals ruled that the Trump administration’s family planning restrictions can go into effect as various lawsuits over the rule play out, reported Politico. The panel of 3 judges granted the administration’s request to lift national injunctions ordered by lower federal courts in Oregon and Washington state, as well as a statewide injunction in California. The panel said that the administration will likely win the legal battle over the Title X family planning program because the Supreme Court upheld similar rules nearly 30 years ago, although they were then reversed by the Clinton administration before taking effect.Missouri’s only abortion clinic said it will defy the state by refusing to perform a required pelvic exam days before an abortion, calling the exam requirement “disrespectful and dehumanizing.” According to The Associated Press, a Planned Parenthood spokeswoman confirmed that as of Thursday, the St. Louis clinic no longer performs the exam during a consultation at least 72 hours before an abortion. The spokeswoman also said that the exam is not required by state law but is an intrusive health department regulation.After US lawmakers alleged that 2 of the World Health Care Organization’s (WHO’s) prescription guidelines for opioids were influenced by the pharmaceutical industry, WHO has withdrawn the guidelines. According to The Wall Street Journal, the organization said it was discontinuing the guidelines “in light of new scientific evidence” and that the move will also “address any issues of conflicts of interest of the experts that have been raised.” The 2 sets of guidelines focused on the availability and accessibility of controlled medicine and the treatment for persisting pain in children with illnesses.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Survey Results Reveal Potential Factors Slowing the Decline in Cardiovascular Mortality Rate
April 23rd 2024Research indicated that worsened glycemic, blood pressure, and obesity control, as well as increased alcohol consumption, leveled lipid control, and persistent socioeconomic disparities may have contributed to the decelerated cardiovascular mortality decline in recent years.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More